Genetic Engineering News: Breaking Genetic Engineering News, Comments and Articles. - Page: 3

Cellectis: Compact TALENTM: the next generation of TAL effector nucleases

The Scientific journal Nature Communications publishes an innovative study on ultra-precise Compact TALENTM mini DNA cutters Regulatory News: Cellectis (Paris:ALCLS) (NYSE PA: ALCLS), the global genome engineering specialist, announced today that the high-impact scientific journal Nature Communications has published an in-house study o...

Seattle Genetics Inc. Presents at UBS Global Healthcare Conference, May-21-2013 11:30 AM

Seattle Genetics, Inc. (SGEN) May 21, 2013 11:30 am ET Executives Clay B. Siegall - Co-Founder, Chairman, Chief Executive Officer and President Presentation Unknown Analyst Good morning, everyone. Thank you for coming to Day 2 of the UBS Healthcare Conference. My name is David Suki [ph]. I'm with the Healthcare Investment Banking team at UBS here in New York. It's my pleasure to introd...

Whole-Genome Sequencing: Clinical Guidelines for Europe

The European Society of Human Genetics has issued guidelines for diagnostic whole-genome sequencing. Medscape Medical News

NHS pilots new genetic testing service for cancer patients

A new programme to develop genetic testing in patients with cancer will be piloted in London within the next six months. The Mainstreaming Cancer Genetics programme has been launched with £2.7m...

Drug Discovery, Step By Step

At risk of being reductive, START-UP asked Myelin Repair Foundation Chief Scientific Officer Mike Gresser, PhD, to outline two drug-discovery approaches: One that starts with a molecular target then finds drugs to match it, the other that starts phen...

Viewpoints: Slowing Health Costs; What Causes Genetic Testing To Be So Expensive; Iowa Governor Offers Medicaid Supports A 'Glimmer Of Hope'

Modern Healthcare: Cost Sustainability We have done it. We have decreased the increase in the cost of healthcare. ... Is this decline the desperately needed bend in the healthcare cost curve or just the impact of the depressed economy? ... A slower growth of healthcare cost would mean less burden on the individual family, freeing that family to invest in and live a higher quality of life. ... The...

Proteostasis Therapeutics Presents Preclinical Data on Parkinson’s Disease and Cystic Fibrosis Targets at EMBO Conference

Proteostasis Therapeutics, Inc., a company developing novel therapeutics that regulate protein homeostasis to improve outcomes for patients with neurodegenerative and orphan diseases, today presented data on the Company’s preclinical targets for Parkinson’s disease and cystic fibrosis at a conference hosted by the European Molecular Biology Organizatio...

Liquidia Technologies Announces Extension of Collaboration with PATH to Develop Next Generation Pneumococcal Vaccine

Company’s Virtual Conjugate Vaccine Program Shows Promise Liquidia Technologies today announced that its collaborative agreement with PATH, a global health nonprofit organization, has been extended. The extension of this agreement allows for the continuation of preclinical proof-of-concept studies on a next generation pneumococcal vaccine. If success...

Flabby Upper Arms Due to Body Type, Age or Weight Loss May Need More than Diet and Exercise to Tone

TARRYTOWN, N.Y., May 21, 2013 /PRNewswire/ -- Body type, age or significant weight loss can prevent some women from achieving tight and toned upper arms despite diligent efforts with diet and exercise, but relatively simple surgical options may offer an alternative. (Photo: http://photos.prnewswire.com/prnh/20130521/NY18209) "Working out and watching calorie intake is the first and optimal...

Cancer Genetics Signs Agreement with MultiPlan

Cancer Genetics, Inc. (OTCQB: CGIX) ("CGI" or the "Company"), a leader in oncology-focused personalized medicine, has entered into an agreement with MultiPlan, Inc. (“MultiPlan”), the industry’s most comprehensive provider of healthcare cost management solutions. As a participating provider in the PHCS and MultiPlan networks, CGI will be abl...

Genetic Predictors of Weight Gain Differ by Gender

Previously identified mutations in genes associated with obesity appear to differentially predict weight gain in men and women, a new 10-year study illustrates. Medscape Medical News

Natural GMOs Part 165. Novel double-stranded RNAs get served up in many conventional crops -- such as rice.

Some people have raised worries about whether novel double-stranded RNA molecules present in plant foods might be harmful to people. Naturally occurring plants often produce novel double-stranded RNA molecules, so we have long been exposed to this risk.One example has been characterised in detail by Japanese scientists. It is low protein variety of rice called  LGC-1 that is used as a diet t...

USC Viterbi Offers New Master's Program in Cyber Security

  LOS ANGELES, May 21, 2013 /PRNewswire-USNewswire/ -- Beginning this fall, the USC Viterbi School of Engineering will offer a Master's program in Cyber Security committed to leveraging advanced technology and educational methods to tackle the most pressing challenges in the digital domain. The program will also be available via the Viterbi School's innovative online delivery me...

Genetic Variation Among Patients With Pulmonary Fibrosis Associated With Improved Survival

Variation in the gene MUC5B among patients with idiopathic pulmonary fibrosis was associated with improved survival, according to a study published online by JAMA. The study is being released early online to coincide with its presentation at the Amer...

Mindray Announces its Recent Filing of Annual Report on Form 20-F with the U.S. Securities and Exchange Commission

SHENZHEN, China, May 21, 2013 /PRNewswire/ -- Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today that on April 8, 2013, it filed with the Securities and Exchange Commission an Annual Report on Form 20-F that included audited financial statements for the year ended December 31, 2012. An electronic ve...

Personal Genome Diagnostics And Blueprint Medicines Form Collaboration to Identify Novel Kinase Targets

BALTIMORE, May 21, 2013 /PRNewswire/ -- Personal Genome Diagnostics Inc. (PGDx), today announced that it will use its proprietary methodologies and expertise in genomic analysis of defined cancer subtypes to identify novel kinase targets in collaboration with Blueprint Medicines.  PGDx is an innovator in conducting patient-specific analyses aimed at identifying genomic alterations in tum...

Promoting STEM Education, Foolishly

Here's a man who says what he thinks about getting students into STEM careers: The United States spent more than US$3 billion last year across 209 federal programmes intended to lure young people into careers in science, technology, engineering and...

Health Canada approves Life's 3500 Dx /3500 xL Dx Genetic Analyzers

Health Canada has approved Life Technologies' applied biosystems 3500 Dx /3500 xL Dx Genetic Analyzers CS2 for diagnostic use.

Pilot Program To Perform Genetic Testing For Breast, Ovarian Cancers

Brett Smith for redOrbit.com - Your Universe Online As part of a public-private collaboration, a UK-based charitable foundation has announced a pilot program to genetically test patients for breast and ovarian cancer. “Recent advances in methods for reading the genetic code, known as sequencing, mean that looking for gene mutations is now faster and more affordable than ever before,” accordi...

Genetic predictors of postpartum depression uncovered

Johns Hopkins researchers say they have discovered specific chemical alterations in two genes that, when present during pregnancy, reliably predict whether a woman will develop postpartum depression.

Genetic markers improve detection of individuals with high risk for CHD

The study comprised over 24,000 Finnish subjects and was led by Professor Samuli Ripatti. The results revealed that a panel of 28 genetic markers improved detection of individuals with high risk for coronary heart disease (10-year risk ≥20%) over t...

Chemical genetics reveals a kinase-independent role for protein kinase R in pyroptosis

Outcome In Head And Neck Cancer Predicted By Genetic Diversity Within Tumors

A new measure of the heterogeneity - the variety of genetic mutations - of cells within a tumor appears to predict treatment outcomes of patients with the most common type of head and neck cancer. In the May 20 issue of the journal Cancer, investigat...

Atossa Genetics to Sponsor Screenings of Decoding Annie Parker at the Seattle International Film Festival on June 6 and 8, 2013

SEATTLE, WA -- (Marketwired) -- 05/21/13 -- Atossa Genetics, Inc. (NASDAQ: ATOS), The Breast Health Company™, is sponsoring two screenings of the new film Decoding Annie Parker at the Seattle International Film Festival on June 6 and 8, 2013. Based on true events, Decoding Annie Parker follows a 15-year war waged on both scientific and emotional fronts by a pair of women demonstrating extreme b...

Genetic diversity predicts outcomes in head and neck cancer

A new measure of the heterogeneity – the variety of genetic mutations – of cells within a tumor appears to predict treatment outcomes of patients with the most common type of head and neck cancer. In the May 20 issue of the journal Cancer, inves...